Soleno Therapeutics (NASDAQ:SLNO) Price Target Raised to $105.00
Soleno Therapeutics (NASDAQ:SLNO – Get Free Report) had its price target upped by stock analysts at Laidlaw from $75.00 to $105.00 in a research note issued to investors on Thursday, Marketbeat Ratings reports. The brokerage currently has a “buy” rating on the stock. Laidlaw’s price objective points to a potential upside of 45.85% from the […]
Soleno Therapeutics (NASDAQ:SLNO – Get Free Report) had its price target upped by stock analysts at Laidlaw from $75.00 to $105.00 in a research note issued to investors on Thursday, Marketbeat Ratings reports. The brokerage currently has a “buy” rating on the stock. Laidlaw’s price objective points to a potential upside of 45.85% from the […]
